This acquisition expands Maruho Medical’s expertise and creates a robust, complementary suite of soft tissue repair solutions for sports medicine surgeons and their patients
Marietta, GA, January 30, 2020 – Maruho Medical, the U.S. orthopedic subsidiary of Maruho Co., Ltd., a leading Japanese dermatological pharmaceutical company, today announced the acquisition of Valeris Medical, an orthopedic surgical device manufacturer.
“This acquisition affords Maruho Medical numerous exciting strategic synergies,” said Eric Cohill, President, Maruho Medical. “It broadens our product line for soft tissue repair procedures, and creates immediate synergies commercially, as well as in manufacturing and operations.
“We could not be more pleased with the opportunity to become a part of Maruho Medical, a company founded on a heritage of medical excellence,” said Tim Lusby, CEO, Valeris Medical.
The acquisition will include full integration of the two companies effective immediately. The deal closed January 24, 2020; terms were not disclosed.
For more information, please contact Maruho Medical at firstname.lastname@example.org or by calling 888-404-3980.
About Valeris Medical
Valeris Medical is an orthopedic surgical device manufacturer. They focus on rapid product development in partnership with strategic surgeon experts to better serve patients and the medical industry. Valeris Medical is headquartered in Marietta, GA.
About Maruho Medical
Maruho Medical is the U.S. orthopedic subsidiary of Maruho Co., Ltd. which has its headquarters in Osaka and leads Japan in research and development, manufacturing and commercialization of dermatological products. Founded in 1915, Maruho has 1,512 employees, and net sales were approximately 78.57 billion yen in its fiscal year ending September 30, 2018. Pursuing its long-term corporate vision, Maruho is striving to improve the health and quality of life of people all over the world.